Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30385366 | 1.00 | SIGMAR1 (0.66) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| Hydrochloric Acid SCHEMBL11674095 | 0.98 | SIGMAR1 (0.63) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL9866200 | 0.84 | SIGMAR1 (0.66) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL28134518 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MEN1KMT2AALDH1A1BCHE | |
| SCHEMBL9407510 | 0.81 | MEN1 (0.56) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL2018449 | 0.81 | MEN1 (0.56) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL16264576 | 0.81 | MEN1 (0.56) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL18909206 | 0.81 | MEN1 (0.54) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL29787785 | 0.81 | MEN1 (0.54) | SIGMAR1MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL11096038 | 0.80 | BCHE (0.71) | SIGMAR1MEN1KMT2AALDH1A1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637439-B2 | Preparation of cannabichromene and related cannabinoids | BAYMEDICA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20230063862-A1 | PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS | BAYMEDICA, INC. | 2023-03-02 | — | — | US | claimed |
| EP-4069418-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2022-10-12 | — | — | EP | claimed |
| CN-114746179-A | Method for producing amines on copper catalysts | 巴斯夫欧洲公司 | 2022-07-12 | — | — | CN | claimed |
| EP-4747296-A1 | ADHESIVE WITH IMPROVED ADHESION ON EPOXY RESIN ADHESIVE REMNANTS | Sika Technology AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-12637439-B2 | Preparation of cannabichromene and related cannabinoids | BAYMEDICA, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12275817-B2 | Hardener for epoxy resins | SIKA TECHNOLOGY AG (CH) | 2025-04-15 | — | — | US | disclosed |
| EP-4284853-B1 | ADDUCT OF ALKYLATED DIAMINE AND NOVOLAK EPOXY RESIN | SIKA TECH AG (CH) | 2025-03-19 | — | — | EP | disclosed |
| WO-2025021660-A1 | ADHESIVE WITH IMPROVED ADHESION ON EPOXY RESIN ADHESIVE REMNANTS | SIKA TECHNOLOGY AG (CH) | 2025-01-30 | — | — | WO | disclosed |
| EP-4495159-A1 | ADHESIVE WITH IMPROVED ADHESION TO EPOXY ADHESIVE RESIDUES | Sika Technology AG (CH) | 2025-01-22 | — | — | EP | disclosed |
| EP-4240799-B1 | SOIL PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | SIKA TECH AG (CH) | 2025-01-08 | — | — | EP | disclosed |
| EP-3861049-B1 | HARDENER FOR EPOXY RESINS | SIKA TECH AG (CH) | 2024-12-11 | — | — | EP | disclosed |
| US-5750804-A | HYDROGENATING 3-ISOCAMPHYLCYCLOHEXANONE USING RUTHENIUM/PHOSPHINE COMPLEX CATALYST IN PRESENCE OF ALKALI METAL OR ALKALINE EARTH METAL AND AMINE BASE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0829463-A2 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1998-03-18 | — | — | EP | disclosed |
| US-4593098-A | Piperazinone and piperazine polypeptides | THE UPJOHN COMPANY (US) | 1986-06-03 | — | — | US | disclosed |
| US-4534897-A | Piperazinone, piperazine, 1,4-diazepin-2-one and 1,4-diazepine intermediate compounds | THE UPJOHN COMPANY (US) | 1985-08-13 | — | — | US | disclosed |
| US-4251438-A | ANALGESICS, PSYCHOTHERAPEUTIC AGENTS | THE UPJOHN COMPANY (US) | 1981-02-17 | — | — | US | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-4120957-A | ANTHELMINTICS | ROHM AND HAAS COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
| US-4010282-A | N,N'-DIBENZYL-ALKYLENE DIAMINES | KNOLL A.G. CHEMISCHE FABRIKEN (DT) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637439-B2 | Preparation of cannabichromene and related cannabinoids | CNR2, CNR1, OPRM1 | SIGMAR1 83/4885MEN1 1301/4885KMT2A 737/4885 |
| US-20230063862-A1 | PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS | CNR2, CNR1, SQLE | SIGMAR1 1625/4885MEN1 932/4885KMT2A 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.